Cinacalcet and achievement of the NKF/K-DOQITM recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study

Cinacalcet Use Patterns and Effect on Laboratory Values and Other Medications in a Large Dialysis Organization, 2004 through 2006

(2009) W. L. St. Peter et al.   Clinical Journal of the American Society of Nephrology

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

(2008) Francesca Tentori et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Consistent Control of Mineral and Bone Disorder in Incident Hemodialysis Patients

(2008) M. D. Danese et al.   Clinical Journal of the American Society of Nephrology

The OPTIMA Study: Assessing a New Cinacalcet (Sensipar/Mimpara) Treatment Algorithm for Secondary Hyperparathyroidism

(2008) P. Messa et al.   Clinical Journal of the American Society of Nephrology

Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD

(2008) T. Isakova et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

(2007) I. Lopez et al.   KIDNEY INTERNATIONAL

Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study

(2007) M. L. Melamed et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION